查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1489413

到 2030 年电子临床结果评估解决方案的全球市场预测：按类型、交付模式、组件、应用、最终用户和区域进行分析

Electronic Clinical Outcome Assessment Solutions Market Forecasts to 2030 - Global Analysis By Type, Delivery Mode, Component, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球电子临床结果评估解决方案市场规模将达到 15 亿美元，预计到 2030 年将达到 48 亿美元，预测期内复合年增长率为 17.2%。

电子临床结果评估 (eCOA) 解决方案透过将患者报告的结果 (PRO)、临床医生评级和观察者报告的结果数位化，简化临床试验中的资料收集。与传统的纸本方法相比，这些数位平台可透过行动装置和入口网站访问，提高资料准确性、患者参与度和试验效率。

根据2022年1月发布的《2016-2020年美国医疗卫生研发投资》报告，联邦政府投资占美国全部医疗卫生研发的四分之一（25%），其中。国立卫生研究院（NIH）占20%（489亿美元）。

临床研究的营运成本和监管要求不断上升

由于复杂性增加、研究持续时间延长以及患者招募成本增加等因素，与临床研究相关的营运成本持续上升，对具有成本效益的解决方案的需求不断增加。 eCOA 解决方案透过简化资料收集、减少手动资料输入的需要、最大限度地减少设施存取和优化资源利用率，提供了节省成本的潜力。越来越多的组织正在采用 eCOA 解决方案来缓解不断上升的营运成本并提高整体测试效率。

缺乏对 eCOA 解决方案的认识

电子临床结果评估解决方案比传统资料收集方法具有许多优势，包括即时资料收集、远端监控功能和简化的工作流程。但是，如果不认识到这些好处，组织可能会继续以低效流程运营，从而导致管理负担增加、成本增加并延迟测试时间表。错过提高效率的机会可能会阻碍临床研究和医疗保健服务的进展。

人们越来越偏好数位资料收集和分析

数位资料收集和分析简化了资料管理流程，从而提高了效率和生产力。电脑化临床结果评估解决方案可自动执行资料输入、资料清理和资料分析等任务，减少管理负担，最大限度地缩短週转时间并加快研究进度。医疗保健提供者、研究人员和製药公司可以更有效地分配资源并专注于核心活动，从而节省成本并更快获得研究结果，从而促进市场成长。

实施和持续维护成本

实施和维护电子临床结果评估解决方案需要专用的资源，例如IT基础设施、人力资源开发和持续支援。资源有限的组织可能难以分配足够的资金和人员来有效实施和管理 eCOA 解决方案。因此，您可能会在优化系统效能、解决技术问题以及满足不断变化的监管要求和行业标准方面面临挑战。

COVID-19 的影响

COVID-19 对 2020 年临床试验的进行和管理产生了负面影响。然而，市场相关人员已经采取了多项措施，例如采用电子临床解决方案来克服这些挑战并确保临床研究活动的连续性。疫情加速了临床试验的数位化。许多临床试验赞助者、生物製药公司、医疗设备公司和 CRO 已采用 eClinical 解决方案来高效地远端收集、管理数据并从资料中提取有价值的见解。电子临床结果评估 (eCOA) 支援远端收集患者资料。

临床医师报告的结果评估（CLINRO）类别预计将成为预测期间最大的类别

由于临床医生在患者报告结果的检验和临床有效性方面发挥关键作用，因此临床医生报告结果评估（CLINRO）领域预计将经历良好的成长。临床医生报告的结果测量 (CLINRO) 透过提供临床背景和专业解释，帮助检验透过 eCOA 解决方案收集的资料。此检验增加了对 eCOA 解决方案测量结果的信心，使其对研究人员、监管机构和医疗保健提供者更有价值。

病患管理和註册领域预计在预测期内复合年增长率最高

患者管理和註册领域预计在预测期内将以最高复合年增长率增长，因为它促进了患者和医疗保健提供者之间更好的沟通。这些系统透过提醒、警报和个人化回馈鼓励患者参与并遵守治疗计划或研究通讯协定。提高病患依从性可以提高临床试验中资料收集的可靠性，并提高电子临床结果评估解决方案所测量结果的有效性。

比最大的地区

由于跨国公司和 CRO 的大量患者群、外包以及临床研究和药物发现支持的投资流，预计亚太地区在预测期内将占据最大的市场占有率。预计这将推动市场成长。印度和中国是大型製药和生物技术公司临床研究外包的主要市场。电子临床平台的采用措施以及主要最终用户和市场参与者的收购预计将在未来几年推动使用。

复合年增长率最高的地区：

由于拥有技术先进的研究中心、医疗设备製造商、大学、医院和设备齐全的医疗设施，北美预计将在未来几年推动开发新药活动，并将在预测期内继续成长。 。此外，由于电子临床解决方案的采用率很高，美国将在 2022 年占据北美最大的市场占有率。因此，EvidentIQ Group 现在可以使用 Dacima 的广泛的端对端 eClinical 解决方案服务，包括 eCOA。

免费客製化服务：

订阅此报告的客户将收到以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球电子临床结果评估解决方案市场：按类型

  • 临床医师报告结果评估 (CLINRO)
  • 患者报告的结果评估 (PRO)
  • 观察员报告结果评估（OBSRO）
  • 绩效结果评估（PERFO）
  • 其他类型

第六章全球电子临床结果评估解决方案市场：以交付方式

  • 本地
  • 网路和云端主机
  • 混合模式

第七章全球电子临床结果评估解决方案市场：按组成部分

  • 服务
  • 软体
  • 穿戴式的
  • 行动装置
  • 其他组件

第八章全球电子临床结果评估解决方案市场：按应用

  • 临床试验
  • 观察性研究与真实世界证据的生成 (RWE)
  • 病患管理及登记
  • 其他用途

第九章全球电子临床结果评估解决方案市场：按最终用户分类

  • 医院和医疗保健提供者
  • 咨询服务公司
  • 政府机关
  • 学术研究所
  • 合约研究组织（CRO）
  • 製药和生物技术公司
  • 医疗科技公司
  • 其他最终用户

第十章全球电子临床结果评估解决方案市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • IBM
  • ArisGlobal
  • Clario
  • Clime do Health GmbH
  • ClinCapture
  • Cloudbyz
  • Curebase Inc.
  • Healthentia
  • ICON Plc
  • IQVIA Inc.
  • Kayentis
  • Medidata Solutions, Inc.
  • Merative
  • ObvioHealth USA, Inc.
  • Oracle Corporation
  • Parexel International（MA）Corporation
  • Signant Health
  • TransPerfect
  • WCG Clinical
  • YPrime, LLC
Product Code: SMRC26199

According to Stratistics MRC, the Global Electronic Clinical Outcome Assessment Solutions Market is accounted for $1.5 billion in 2023 and is expected to reach $4.8 billion by 2030 growing at a CAGR of 17.2% during the forecast period. Electronic Clinical Outcome Assessment (eCOA) solutions streamline data collection in clinical trials by digitizing patient-reported outcomes (PROs), clinician assessments, and observer-reported outcomes. These digital platforms, accessible via mobile devices or web portals, enhance data accuracy, patient engagement, and trial efficiency compared to traditional paper-based methods. eCOA solutions facilitate real-time data capture, remote monitoring, and customizable assessments tailored to specific trial protocols.

According to the 'U.S. Investments in Medical and Health Research and Development 2016-2020' report released in January 2022, federal government investment constituted one-quarter (25%) of all medical and health R&D in the U.S., totaling USD 61.5 billion, with the National Institutes of Health (NIH) accounting for 20% (USD 48.9 billion) of such investment in 2020.

Market Dynamics:

Driver:

Rising operational costs and regulatory requirements associated with clinical research studies

As operational costs associated with clinical research studies continue to rise due to factors such as increased complexity, longer study durations, and higher patient recruitment expenses, there is a growing demand for cost-efficient solutions. eCOA solutions offer a potential avenue for cost savings by streamlining data collection, reducing the need for manual data entry, minimizing site visits, and optimizing resource utilization. Organizations are increasingly adopting eCOA solutions to mitigate rising operational costs and improve overall study efficiency.

Restraint:

Lack of awareness about eCOA solutions

Electronic clinical outcome assessment solutions offer numerous advantages over traditional data collection methods, including real-time data capture, remote monitoring capabilities, and streamlined workflows. However, without awareness of these benefits, organizations may continue to operate with inefficient processes, leading to increased administrative burden, higher costs, and slower study timelines. Missed opportunities for efficiency can hinder progress in clinical research and healthcare delivery.

Opportunity:

Growing preference for digital data collection and analysis

Digital data collection and analysis streamline data management processes, leading to improved efficiency and productivity. Electronic clinical outcome assessment solutions automate tasks such as data entry, data cleaning, and data analysis, reducing administrative burden, minimizing turnaround times, and accelerating study timelines. Healthcare providers, researchers, and pharmaceutical companies can allocate resources more effectively and focus on core activities, leading to cost savings and faster research outcomes propelling the market growth.

Threat:

Cost of implementation and ongoing maintenance

Implementing and maintaining electronic clinical outcome assessment solutions requires dedicated resources, including IT infrastructure, personnel training, and ongoing support. Organizations with limited resources may struggle to allocate sufficient funds and personnel to implement and manage eCOA solutions effectively. As a result, they may face challenges in optimizing system performance, addressing technical issues, and keeping pace with evolving regulatory requirements and industry standards.

Covid-19 Impact

COVID-19 adversely impacted the conduction and management of clinical trials in 2020. However, market stakeholders implemented several measures such as the adoption of eClinical solutions to overcome these challenges and to ensure the continuity of clinical research activities. The pandemic thus helped catalyze the digitalization of clinical trials. Many sponsors, Biopharma companies, medical device firms, & CROs began adopting eClinical solutions to collect data, manage it, and draw useful insights effectively and remotely. Electronic clinical outcomes assessments (eCOAs) support the collection of patient data remotely.

The clinician reported outcome assessment (CLINRO) segment is expected to be the largest during the forecast period

The clinician reported outcome assessment (CLINRO) segment is estimated to have a lucrative growth, as clinicians play a crucial role in interpreting patient-reported outcomes and validating their clinical relevance. Clinician reported outcome assessment assessments help validate the data collected via eCOA solutions by providing clinical context and professional interpretation. This validation enhances the credibility of outcomes measured by eCOA solutions, making them more valuable to researchers, regulators, and healthcare providers.

The patient management & registries segment is expected to have the highest CAGR during the forecast period

The patient management & registries segment is anticipated to witness the highest CAGR growth during the forecast period, as they facilitate better communication between patients and healthcare providers. Through reminders, alerts, and personalized feedback, these systems encourage patient engagement and adherence to treatment plans or study protocols. Improved patient compliance leads to more reliable data collection in clinical trials, enhancing the validity of outcomes measured by electronic clinical outcome assessment solutions.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the large patient pools, outsourcing, and the flow of investment by MNCs and CROs to support clinical research and drug discovery. This is projected to enhance the market growth. India and China are the key markets for clinical research outsourcing for major pharma & biotech companies. Initiatives and acquisitions pertaining to the adoption of eClinical platforms undertaken by key end-users and market players are anticipated to boost usage in the coming years.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the presence of technologically advanced research centers, medical device manufacturers, universities, and hospitals coupled with improved healthcare establishments are expected to drive new drug development activities in the coming years. Moreover, U.S. accounted for the largest market share of North America in 2022, owing to the higher adoption levels of eClinical solutions. As a result, the EvidentIQ Group now has access to Dacima's broad service offering for end-to-end eClinical solutions which includes eCOA.

Key players in the market

Some of the key players in the Electronic Clinical Outcome Assessment Solutions Market include IBM, ArisGlobal, Clario, Clime do Health GmbH, ClinCapture, Cloudbyz, Curebase Inc, Healthentia, ICON Plc, IQVIA Inc., Kayentis, Medidata Solutions, Inc., Merative, ObvioHealth USA, Inc., Oracle Corporation, Parexel International (MA) Corporation, Signant Health, TransPerfect, WCG Clinical and YPrime, LLC

Key Developments:

In January 2024, Fortinet and IBM Cloud Collaborate to Help Clients Protect Their Workloads from Increased Cybersecurity Threats. With clients reporting that they are facing new network and application threats, it's critical to have the right ecosystem of technology partners that can unite around a shared mission of protecting their clients from risk.

In January 2024, IBM and The Government of Spain Collaborate to Advance National AI Strategy and Build the World's Leading Spanish Language AI Models. That will allow the development of foundational models for Artificial Intelligence, native in Spanish and co-official languages.

In January 2024, ArisGlobal, an innovative life sciences technology company and creator of LifeSphere(R), revealed details about its Advanced Intake powered by LifeSphere NavaX, the company's next-generation advanced cognitive computing engine.

Types Covered:

  • Clinician Reported Outcome Assessment (CLINRO)
  • Patient Reported Outcome Assessment (PRO)
  • Observer Reported Outcome Assessment (OBSRO)
  • Performance Outcome Assessment (PERFO)
  • Other Types

Delivery Modes Covered:

  • On-Premise
  • Web & Cloud Hosted
  • Hybrid Model

Components Covered:

  • Services
  • Software
  • Wearables
  • Mobile Devices
  • Other Components

Applications Covered:

  • Clinical Trials
  • Observational Studies & Real-World Evidence (RWE) Generation
  • Patient Management & Registries
  • Other Applications

End Users Covered:

  • Hospitals & Healthcare Providers
  • Consulting Service Companies
  • Government Organizations
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Pharmaceutical & Biotechnology Companies
  • Medtech Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Electronic Clinical Outcome Assessment Solutions Market, By Type

  • 5.1 Introduction
  • 5.2 Clinician Reported Outcome Assessment (CLINRO)
  • 5.3 Patient Reported Outcome Assessment (PRO)
  • 5.4 Observer Reported Outcome Assessment (OBSRO)
  • 5.5 Performance Outcome Assessment (PERFO)
  • 5.6 Other Types

6 Global Electronic Clinical Outcome Assessment Solutions Market, By Delivery Mode

  • 6.1 Introduction
  • 6.2 On-Premise
  • 6.3 Web & Cloud Hosted
  • 6.4 Hybrid Model

7 Global Electronic Clinical Outcome Assessment Solutions Market, By Component

  • 7.1 Introduction
  • 7.2 Services
  • 7.3 Software
  • 7.4 Wearables
  • 7.5 Mobile Devices
  • 7.6 Other Components

8 Global Electronic Clinical Outcome Assessment Solutions Market, By Application

  • 8.1 Introduction
  • 8.2 Clinical Trials
  • 8.3 Observational Studies & Real-World Evidence (RWE) Generation
  • 8.4 Patient Management & Registeries
  • 8.5 Other Applications

9 Global Electronic Clinical Outcome Assessment Solutions Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Healthcare Providers
  • 9.3 Consulting Service Companies
  • 9.4 Government Organizations
  • 9.5 Academic & Research Institutes
  • 9.6 Contract Research Organizations (CROs)
  • 9.7 Pharmaceutical & Biotechnology Companies
  • 9.8 Medtech Companies
  • 9.9 Other End Users

10 Global Electronic Clinical Outcome Assessment Solutions Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 IBM
  • 12.2 ArisGlobal
  • 12.3 Clario
  • 12.4 Clime do Health GmbH
  • 12.5 ClinCapture
  • 12.6 Cloudbyz
  • 12.7 Curebase Inc.
  • 12.8 Healthentia
  • 12.9 ICON Plc
  • 12.10 IQVIA Inc.
  • 12.11 Kayentis
  • 12.12 Medidata Solutions, Inc.
  • 12.13 Merative
  • 12.14 ObvioHealth USA, Inc.
  • 12.15 Oracle Corporation
  • 12.16 Parexel International (MA) Corporation
  • 12.17 Signant Health
  • 12.18 TransPerfect
  • 12.19 WCG Clinical
  • 12.20 YPrime, LLC

List of Tables

  • Table 1 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Clinician Reported Outcome Assessment (CLINRO) (2021-2030) ($MN)
  • Table 4 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Patient Reported Outcome Assessment (PRO) (2021-2030) ($MN)
  • Table 5 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Observer Reported Outcome Assessment (OBSRO) (2021-2030) ($MN)
  • Table 6 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Performance Outcome Assessment (PERFO) (2021-2030) ($MN)
  • Table 7 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Delivery Mode (2021-2030) ($MN)
  • Table 9 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By On-Premise (2021-2030) ($MN)
  • Table 10 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Web & Cloud Hosted (2021-2030) ($MN)
  • Table 11 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Hybrid Model (2021-2030) ($MN)
  • Table 12 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Component (2021-2030) ($MN)
  • Table 13 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Services (2021-2030) ($MN)
  • Table 14 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Software (2021-2030) ($MN)
  • Table 15 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Wearables (2021-2030) ($MN)
  • Table 16 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Mobile Devices (2021-2030) ($MN)
  • Table 17 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 18 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Application (2021-2030) ($MN)
  • Table 19 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Clinical Trials (2021-2030) ($MN)
  • Table 20 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Observational Studies & Real-World Evidence (RWE) Generation (2021-2030) ($MN)
  • Table 21 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Patient Management & Registeries (2021-2030) ($MN)
  • Table 22 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 23 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By End User (2021-2030) ($MN)
  • Table 24 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Hospitals & Healthcare Providers (2021-2030) ($MN)
  • Table 25 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Consulting Service Companies (2021-2030) ($MN)
  • Table 26 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Government Organizations (2021-2030) ($MN)
  • Table 27 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 28 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 29 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 30 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Medtech Companies (2021-2030) ($MN)
  • Table 31 Global Electronic Clinical Outcome Assessment Solutions Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.